Chresta, Christine M <br/><br/>
AZD8055 is a potent, selective, and orally bioavailable ATP-competitive mammalian target of rapamycin kinase inhibitor with in vitro and in vivo antitumor activity.  [electronic resource] 

 -  Cancer research  Jan 2010 
 - 288-98 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1538-7445 
<br/><br/><label>Standard No.: </label>10.1158/0008-5472.CAN-09-1751  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Antineoplastic Agents--pharmacology<br/>Cell Proliferation--drug effects<br/>Female<br/>Humans<br/>Mice<br/>Mice, Nude<br/>Morpholines--pharmacology<br/>Neoplasms, Experimental--drug therapy<br/>Protein Kinase Inhibitors--pharmacology<br/>Protein Kinases--drug effects<br/>Signal Transduction--drug effects<br/>TOR Serine-Threonine Kinases<br/>Xenograft Model Antitumor Assays